DoD Joint Warfighter Medical, Military Medical Research and Development Award | HT9425 23 S JWMRP MMRDA

Opportunity Information: Apply for HT9425 23 S JWMRP MMRDA

The DoD Joint Warfighter Medical, Military Medical Research and Development Award (MMRDA) is a Department of Defense funding opportunity run through the U.S. Army Medical Research and Development Command (USAMRDC), with administrative support from USAMRAA. It is designed to push existing military-relevant medical research forward rather than start brand-new exploratory projects. The core purpose is to fund the logical continuation of previously funded work from prior years, specifically projects that align with the FY23 Joint Warfighter Medical Research Program (JWMRP) Focus Areas and that show strong potential to accelerate real-world medical products or practical health care solutions. The intended beneficiaries include military Service Members and Veterans, their families, other Military Health System (MHS) beneficiaries, and in many cases the broader American public when the resulting products or care approaches have civilian applicability.

This mechanism is oriented toward later-stage efforts where there is already a foundation of data or development progress and the next step is to mature the work toward deployment, adoption, or product readiness. In practical terms, the program supports a broad range of applied research and development activities, including late-stage preclinical studies, late-stage technology development, technology demonstration, and translational research. The emphasis on translation and demonstration signals that the DoD is looking for outcomes that move beyond basic science and closer to usable tools, interventions, devices, diagnostics, therapeutics, or operational medical capabilities that can be integrated into military medicine or health care delivery.

USAMRDC may fund selected efforts using several different award pathways, depending on what best fits the project and the government’s needs. The announcement notes that awards may be made as assistance agreements (grants and cooperative agreements), research contracts (procurements), or Other Transaction Agreements (OTAs). This mix matters because each pathway carries different expectations for government involvement, deliverables, and compliance structure. Cooperative agreements, for example, often imply more substantial programmatic involvement by the government compared with a standard grant, while contracts are typically used when the government is acquiring specific deliverables. OTAs can provide additional flexibility for certain R&D and prototyping activities.

Eligibility is listed as unrestricted, meaning the opportunity is generally open to a wide variety of applicant types (such as universities, nonprofits, small businesses, large businesses, and other organizations), subject to any additional constraints described in the full announcement. A notable practical detail is that the announcement indicates “all invited applicants must submit full applications,” which typically means this mechanism may operate on an invitation-only basis after some prior screening or prior award history. Applicants are expected to follow the application procedures in the funding opportunity announcement and to ensure their proposed work clearly represents a continuation of prior DoD-relevant research or development.

Collaboration with DoD organizations is explicitly encouraged when it improves the likelihood of success, such as leveraging specialized military labs, access to unique datasets or facilities, or alignment with operational requirements. If a project includes funds directed to DoD laboratories or other DoD activities, the application is expected to identify those costs using a specific budget format referred to as the “Suggested Collaborating DOD Military Facility Budget Format” (Attachment 15). This requirement is meant to make inter-organization roles, costs, and contributions transparent and auditable.

From the source details provided, the opportunity number is HT9425 23 S JWMRP MMRDA, the CFDA number is 12.420, the activity category is Science and Technology and other Research and Development, and the agency is the Department of Defense (Department of the Army - USAMRAA). The posting lists an expected number of awards of four. The award ceiling is shown as 0, which commonly indicates that a fixed maximum was not specified in the summary record (applicants usually need to consult the full funding announcement for any budget limits, typical award sizes, or constraints tied to project scope). The opportunity was created on April 18, 2023, with an original closing date of September 7, 2023.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Joint Warfighter Medical, Military Medical Research and Development Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Apr 18, 2023.
• Applicants must submit their applications by Sep 07, 2023. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 4 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for HT9425 23 S JWMRP MMRDA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: